Cite
HARVARD Citation
Lee, K. et al. (2019). Randomised phase 3 trial: tegoprazan, a novel potassium‐competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis. Alimentary pharmacology & therapeutics. 49 (7), pp. 864-872. [Online].